NEW YORK STATE COMMON RETIREMENT FUND - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 76 filers reported holding CUE BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$28
-70.2%
11,984
-53.4%
0.00%
Q2 2023$94
-90.6%
25,700
+9279.6%
0.00%
Q2 2022$1,000
-98.9%
274
-98.5%
0.00%
Q1 2022$89,000
-56.6%
18,211
+0.3%
0.00%
Q4 2021$205,000
-22.9%
18,152
-0.4%
0.00%
Q3 2021$266,000
-11.0%
18,229
-28.9%
0.00%
Q2 2021$299,000
-3.5%
25,642
+1.0%
0.00%
Q1 2021$310,000
-2.5%
25,4000.0%0.00%
Q4 2020$318,000
-16.8%
25,4000.0%0.00%
Q3 2020$382,000
-38.7%
25,4000.0%0.00%
-100.0%
Q2 2020$623,000
+133.3%
25,400
+35.1%
0.00%
Q1 2020$267,000
-10.4%
18,8000.0%0.00%
Q4 2019$298,000
+227.5%
18,800
+74.1%
0.00%
Q3 2019$91,000
-6.2%
10,8000.0%0.00%
Q2 2019$97,000
+304.2%
10,800
+248.4%
0.00%
Q1 2019$24,000
+60.0%
3,1000.0%0.00%
Q4 2018$15,000
-91.6%
3,100
-84.3%
0.00%
Q3 2018$178,000
-23.9%
19,7000.0%0.00%
Q2 2018$234,00019,7000.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Corriente Advisors, LLC 820,000$11,636,00012.56%
Prosight Management, LP 552,060$7,834,0003.66%
Nantahala Capital Management 2,503,840$35,529,0001.33%
MANGROVE PARTNERS IM, LLC 601,398$8,534,0001.18%
Voss Capital, LLC 88,670$749,0001.00%
Slate Path Capital LP 870,694$12,355,0000.95%
Avoro Capital Advisors LLC 1,870,000$26,535,0000.90%
Bleichroeder LP 165,000$2,341,0000.61%
683 Capital Management, LLC 640,000$9,082,0000.54%
PA Capital LLC 40,706$578,0000.51%
View complete list of CUE BIOPHARMA INC shareholders